New research found that establishing complete trauma care programs accessible to 100% of road injury victims could save the lives of 200,000 people annually.
A three-year, $15 million partnership between Cornell and NewYork-Presbyterian will employ artificial intelligence to help improve outcomes for people with cardiovascular disease.
There is considerable variation in the management of mantle cell lymphoma across different clinical settings according to an analysis by investigators.
Post-operative atrial fibrillation may be a marker for early-stage heart failure and may potentially contribute to its development, according to a new study.
Three Cornell scientists were honored during a June 1 ceremony promoting women’s engagement in innovation and commercialization – part of Cornell’s efforts to elevate women inventors, who were awarded just 12.8% of all U.S. patents in 2019.
A multidisciplinary team of Cornell researchers is collaborating to elevate the value of home care workers while improving their working conditions and patient outcomes.
As the pandemic pomp and COVID circumstances dissipate, Cornell’s McGovern Center and Praxis Center incubators graduated five startups, putting them on the road to success.
A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
The annual event showcased the wide range of cancer research taking place across Cornell colleges and campuses, and allowed faculty and students to identify potential areas for collaboration.
